Dr. John Carlo, CEO of Prism Health North Texas (PHNTX), has been named chair of the Texas Medical Association (TMA) Council on Legislation, the council that develops and implements TMA legislative policies at state and national levels. As part of his nearly two decades of service in different health care leadership roles, Dr. Carlo has been appointed chair of the council after serving as a council member since 2018. He also has served as chair of the TMA Council on Socioeconomics and as chair of the TMA Council on Science and Public Health. Since March 2020, Dr. Carlo has served as a member of the TMA COVID-19 Task Force, guiding Texans on how to make safe and informed decisions about their health throughout the pandemic.
“The Texas Medical Association unifies the voice of over 50,000 physicians across the state to advocate on behalf of our patients,” said Dr. Carlo. “I look forward to working with the great TMA staff and physician members in this new role.”
Dr. Carlo’s appointment to the TMA Council on Legislation is due in part to his work as chair of the Texas Public Health Coalition, which was instrumental in the passage of legislation that raised the minimum age to 21 for buying tobacco in Texas. The council on legislative chair position is a one-year appointment, and Dr. Carlo looks forward to facilitating the many different legislative priorities of the TMA.
“We have a lot of work to do,” says Dr. Carlo in regard to upcoming goals for the session. “Far too many Texans lack access to affordable healthcare, resulting in far too many treatable conditions left untreated.”
“The adage of ‘the right person for the right position at the right time,’ has never rung more true, than the appointment of John Carlo, MD to chair the TMA Council on Legislation,” said Dr. Mark Casanova, director of clinical ethics and supportive and palliative care at Baylor University Medical Center at Dallas. “John brings the breadth of experience and real-world public health knowledge, coupled with an innate equanimity that positions him to be an effective leader of the COL, but more importantly, an effective advocate for the House of Medicine and the myriad of necessary legislative interfaces, at local, state, and even national levels.”